CompletedNCT03935854
Official study titleImpact of A Low-Carbohydrate, High-Fat, Ketogenic Diet on Obesity, Metabolic Abnormalities and Psychiatric Symptoms in Patients With Bipolar or Schizophrenia Illness: A Pilot Trial
This study has finished and is no longer accepting participants.
In StanfordBipolarity, SchizophreniaInterventional studyAges 18–75
- Countries
- United States
- Sponsor
- Stanford University
CompletedNCT00442039
Official study titlePediatric Pharmacokinetic and Tolerability Study of Lithium for the Treatment of Pediatric Mania Followed by an Open Label Long Term Safety Period, Discontinuation Phase, and Restabilization Period.
This study has finished and is no longer accepting participants.
In ClevelandBipolarity, SchizophreniaMedication studyAges 7–17
- Countries
- United States
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CompletedNCT06652308
Official study titleFrequency of Unipolar and Bipolar Mood Disorders in Patients with Multiple Sclerosis: a Retrospective Cohort Study
This study has finished and is no longer accepting participants.
In JinanBipolarity, DepressionObservational studyAges 18–65
- Countries
- China
- Sponsor
- Islamic Azad University, Sanandaj
CompletedNCT04701866
Official study titleMusic as a Potential Intervention to Improve Hemodynamic Tolerability of Repetitive Sub-Anesthetic IV Ketamine Infusions in Bipolar and Unipolar Depression: A Pilot Study
This study has finished and is no longer accepting participants.
In MontrealDepression, BipolarityInterventional studyAges 18–75
- Countries
- Canada
- Sponsor
- Douglas Mental Health University Institute
CompletedNCT07140042
Official study titleComparison of Physical Fitness, Physical Activity Level, Depression and Quality of Life in Bipolar and Schizophrenia Patients With Healthy Controls
This study has finished and is no longer accepting participants.
In IstanbulBipolarity, Depression, ...Observational studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Dr. Lutfi Kirdar Kartal Training and Research Hospital
CompletedEUCTR 2007-003867-36
Official study titlePILOT STUDY OF PHARMACOGENETICS, CLINICAL EFFICACY AND TOLERABILITY OF CLOZAPINE IN PATIENTS AFFECTED BY SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDERS AND BIPOLAR DISORDERS WITH PSYCHOTIC FEATURES
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In ItalyBipolarity, SchizophreniaHistorical research record
- Countries
- Italy
- Sponsor
- AZIENDA OSPEDALIERA PISANA
CompletedNCT04127604
This study has finished and is no longer accepting participants.
In ProvidenceBipolarity, AddictionBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- VA Office of Research and Development (Government agency)
CompletedNCT00044616
Official study titleRelapse Prevention of Bipolar Type-II Disorder
This study has finished and is no longer accepting participants.
In PhiladelphiaBipolarity, DepressionMedication studyAges 18–100
- Countries
- United States
- Sponsor
- University of Pennsylvania
CompletedNCT01644747
Official study titletDCS as an add-on Treatment for Resistant Major Depression in Uni- or Bipolar Patients: a Randomized, Double-blind, Placebo Controlled Study
This study has finished and is no longer accepting participants.
Multiple locations, including BesançonBipolarity, DepressionDevice studyAges 18–65
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Besancon
CompletedNCT02466685
Official study titleTesting the Ability of JNJ(Janssen and Janssen)18038683, a Selective Serotonin (5-HT)7 Antagonist, to Improve Cognition and Reduce Residual Depressive Symptoms in Stable Bipolar Patients (18038683BCD2001)
This study has finished and is no longer accepting participants.
In ChicagoBipolarity, DepressionMedication studyAges 18–60
- Countries
- United States
- Sponsor
- Herbert Meltzer
CompletedNCT00183443
Official study titleDivalproex Extended Release and Placebo, Lithium, or Quetiapine for Mania
This study has finished and is no longer accepting participants.
In Palo AltoBipolarity, SchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Palo Alto Veterans Institute for Research
CompletedNCT00158990
Official study titleTriiodothyronine (T3) Supplementation in Bipolar and Unipolar Depression: A Random Assignment, Double Blind, Placebo-Controlled Study.
This study has finished and is no longer accepting participants.
Multiple locations, including PrincetonBipolarity, DepressionMedication studyAges 18–70
- Countries
- United States, Israel
- Sponsor
- Hadassah Medical Organization